The global PICC Line Market is forecast to reach USD 1,278.3 Million by 2028, according to a new report by Reports and Data. A peripherally inserted central catheter (PICC or PIC line), which is also called a percutaneous indwelling central catheter, is a type of of intravenous access. It can be applied for a prolonged period like for extended antibiotic therapy,  long chemotherapy regimens, and for administration of substances, among others. A PICC is inserted in the arm in a peripheral vein like basilic vein, brachial vein, or cephalic vein, followed by which it is advanced proximally towards the heart through increasingly larger veins till it reaches cavoatrial junction or distal superior vena cava. It is usually inserted by physician assistants, physicians, specially trained certified registered nurses respiratory therapists, radiologist assistants, and radiologic technologists using chest radiographs, fluoroscopy, and ultrasound to ascertain its insertion and ensure placement.

The insertion process is a sterile procedure; however, it doesnot require an operating room. When it is performed in homecare, an appropriate sterile field is needed to be maintained throughout the procedure. Supporting market factors like the rise in the incidence rate of chronic conditions, favorable reimbursement policies, and increasing expenditure in the healthcare sector are propelling the growth of the market. In regards to region, Europe can be seen to occupy a prominent market share. The market share held by the region is attributed to expanding healthcare sector, rising geriatric population and high incidence rate of chronic conditions.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/2441

Further key findings from the report suggest

  • The PICC Line market held a market share of USD 748.4 Million in the year 2018 that is forecasted to grow at a rate of 5.30% during the forecast period.
  • In context to Product Type, the Power injected PICC Line segment generated a higher revenue of USD 595.0 Million in 2018, with a CAGR of 6.1% during the forecast period. The rise in accident and emergency cases in hospitals and applicability of these catheters in the ICUs wherein it can be used for hemodynamic monitoring, multipurpose central lines for any infusion, and high-pressure injection of contrast media at the time of radiological procedures results in its high demand and the revenue generated by this segment.
  • In context to Application, the Chemotherapy segment is projected to witness the fastest growth rate of 6.9% during the forecast period, which is expected to occupy 19.0% by 2027. The rising incidence rate of cancer and associated elevated demand for chemotherapy results in increasing application of PICCs in this segment that contributes to the growth rate witnessed by this segment.
  • In regards to End-user, the Hospitals segment held the largest market share of 57.0% in 2018, with a CAGR of 5.7% during the forecast period. The market share held by the Hospitals segment is attributed to a large number of surgeries being performed in hospitals, which results in high demand for these catheters in this end-user. Furthermore, continuous development in the healthcare infrastructure in developing nations and increasing hospital admissions due to chronic conditions also contributes to the market share held by this segment.
  • In regards to the region, Asia Pacific is projected to witness the fastest growth rate of 9.0% during the forecast, which is expected to hold 0% of the market by 2027. The growth rate witnessed by the region is resultant of developing healthcare infrastructure and increasing incidence rate of chronic diseases in this region.

Competitive Outlook of the Global PICC Line Market

The globla PICC Line market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the PICC Line market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers & acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.

Top Companies Profiled in the Report:

  1. Bard Inc., AngioDynamics, Inc., B. Braun Melsungen AG, Teleflex Incorporated, Vygon S.A, Medtronic plc, Becton, Dickinson and Company, Cook Medical, Inc., Medical Component Inc., and Argon Medical Devices, Inc.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2441

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

PICC Line Market Segmentation:

Product Type Outlook (Revenue, USD Million; 2018-2028)

  • Conventional PICC Line
  • Power injected PICC Line

Design Type Outlook (Revenue, USD Million; 2018-2028)

  • Multiple Lumen
  • Double Lumen
  • Single Lumen

Application Outlook (Revenue, USD Million; 2018-2028)

  • Intravenous Fluids
  • Chemotherapy
  • Blood Transfusions
  • Other drugs

End-user Outlook (Revenue, USD Million; 2018-2028)

  • Hospitals
  • Nursing Facility
  • Ambulatory Surgical Centers
  • Homecare

Geographic Segment Covered in the Report:

The PICC Line report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

  • North America (USA and Canada)
  • Europe (UK, Germany, France and the rest of Europe)
  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
  • Latin America (Brazil, Mexico, and the rest of Latin America)
  • Middle East and Africa (GCC and rest of the Middle East and Africa)

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2441

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Optical Microscope Market @ https://www.biospace.com/article/advancements-in-nanotechnology-and-biotechnology-are-the-driving-factors-of-the-optical-microscope-market-growth-by-2025/

Artificial Tears Market @ https://www.biospace.com/article/the-artificial-tears-market-is-anticipated-to-witness-fast-paced-development-over-the-upcoming-years/

Naphazoline Hydrochloride, Chlorphenamine Maleate & Vitamin B12 Eye Drops Market @ https://www.biospace.com/article/naphazoline-hydrochloride-chlorphenamine-maleate-and-vitamin-b12-eye-drops-market-growth-2022-2028-rising-number-of-people-engage-in-different-activities-including-swimming-and-wearing-hard-contact-lenses/

Purified Human Proteins Market @ https://www.biospace.com/article/purified-human-proteins-market-size-is-estimated-to-reach-usd-93-78-million-by-2027-at-a-cagr-of-13-percent-reports-and-data/

Atherectomy Market @ https://www.biospace.com/article/atherectomy-market-will-reach-usd-2-01-billion-by-2028-/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com